IcoSApent ethyL to Slow Down Aortic VAlve Stenosis proGrEssion
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 110 participants.
Also called NCT06466278
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 110 participants
- Registry
-
NCT06466278
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06466278. Randomized; quadruple masking; primary purpose treatment. Start 2023-06-01 (actual); primary completion 2026-07-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- IcoSApent ethyL to Slow Down Aortic VAlve Stenosis proGrEssion
- Acronym
- SALVAGE
- Condition
- Aortic Valve Stenosis
- Intervention (Drug)
- Icosapent ethyl
- Intervention (Drug)
- Placebo
- Lead sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Record details
- Record id
cardio:ct-nct06466278- Content hash
881f2a7d9edeb09cff2eac3d50c56960a879a83f3cccfdb2a142229648d80f9d